1Spangel MJ, Masri BA, O'Connell JX, et al. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg (Am), 1999, 81: 672-683.
2Niskanen RO, Korkala O, Pammo H. Serum C-reactive protein levels after total hip and knee arthroplasty. J Bone Joint Surg (Br) , 1996, 78: 431-433.
3Konig DP, Schierholz JM, Hilgers RD, et al. In vitro adherence and accumulation of Staphylococcus epidermidis RP 62 A and Staphylococcus epidermidis M7 on four different bone cements. Langenbecks Arch Surg, 2001, 386: 328-332.
4Chiu FY, Lin CF, Chen CM, et al. Cefuroxime-impregnated cement at primary total knee arthroplasty in diabetes mellitus. A prospective, randomized study. J Bone Joint Surg (Br), 2001, 83: 691-695.
5Elson RA, Jephcott AE, McGechie DB, et al. Antibiotic-loaded acrylic cement. J Bone Joint Surg (Br), 1977, 59: 200-205.
6Blomgren G, Lindgren U. Late hematogenous infection in total joint replacement: studies of gentamicin and bone cement in the rabbit. Clin Orthop, 1981, (155): 244-248.
7Southwood RT, Rice JL, McDonald PJ, et al. Infection in experimental arthroplasties. Clin Orthop, 1987, (224): 33-36.
8Cremieux AC, Carbon C. Experimental models of bone and prosthetic joint infections. Clin Infect Dis, 1997, 25: 1295-1302 .
9White J, Kelly M, Dunsmuir R. C-reactive protein level after total and total knee replacement. J Bone Joint Surg (Br), 1998, 80: 909-911.
